VERITY PHARMA NOUVELLES

Toronto, Canada, December 18, 2017 – Verity Pharmaceuticals Inc., (“Verity” or the “Company”) a specialty pharmaceutical company announced today the appointment of Mr. Allan Silber to the Board of Directors.

Mr. Howard Glase, Verity Chief Executive Officer, noted that: “As an emergent specialty pharmaceutical company filling an unmet need in the Canadian health care landscape, we are extremely pleased to be able to benefit from Mr. Silber’s knowledge and successes in the specialty health care space. Moreover, Mr. Silber’s extensive financial and strategic planning expertise will add to the strength of the Verity Board. Mr. Silber is a solid cornerstone to our corporate platform.”

With respect to Mr. Silber’s health care companies, he was the Chairman of the Board of Capstone Pharmacy Services, Inc., an American institutional pharmacy services provider, and Stadtlander Drug Co., Inc., a specialty retail pharmacy organization. Mr. Silber structured several financings and a public offering for Capstone, raising over US$100 million, as well as negotiating its merger with Pharmacy Corporation of America, creating PharMerica Inc., a transaction valued at US$840 million. Stadtlander was a leading US provider of disease specific pharmaceutical care to high risk, high cost patient populations including transplant recipients and HIV/AIDS, oncology and infertility patients. After significant growth and success under Mr. Silber’s leadership, Stadtlander was sold to Bergen Brunswig Corporation.

Mr. Silber has an extensive background in the private equity and financial services fields. He is currently the Chairman of the Board of Street Capital Group Inc., a Canadian public company that he founded in 1979. He is also the Chairman of the Board of Street Capital’s former subsidiary, Heritage Global Inc., a U.S. public company and United States Security and Exchange Commission registrant. He has founded and managed a number of companies as well as led many mergers, acquisitions and financings.

Mr. Silber is actively involved in several cultural, charitable and community-based organizations, including participation at the board level, and has been chairman of numerous fundraising events for community-based and international organizations. He has been recognized for his philanthropic work by the Jewish National Fund, in regards to community leadership and dedication to public service. Mr. Silber attended McMaster University and received a BSc from the University of Toronto.

Contact Information:
Howard Glase
General Manager & Chief Executive Officer
Email: publicrelations@veritypharma.com

About Verity Pharmaceuticals Inc.
Verity Pharmaceuticals Inc. is a Canadian privately owned and operated specialty pharmaceutical company, dedicated to providing access to pharmaceutical products which have been withdrawn from the Canadian market, in short-drug supply, or currently not commercially available. Verity has numerous specialty products under license and currently registering these prescription products with Health Canada. By working with innovative international pharmaceutical organizations, as well as a highly qualified team of physicians, executives and investors, Verity Pharmaceuticals aims to ensure a predictable high-quality supply of products for the Canadian market.